Results of a randomized, placebo-controlled, first-in-human trial of topical CY-002 in patients with cutaneous warts

Author(s):: Pagan, L.; Yfanti, C.; Rijneveld, R.; Todd, M.; Jongste, P.; Feijen, J.J.; Klaassen, E.S.; Bouwes Bavinck, J.N.; Struijk, L.; Koning, M.N.C. de; Prestegarden, L.; Niemeyer-van der Kolk, T.; Poelgeest, M.I.E.; Rissmann, R.

Published: 2022
Publication type: Article / Letter to editor

Date issued: 2022-12-01
Language: English
Is part of: Journal of the European Academy of Dermatology and Venereology (2022), Vol. 36, no. 10, p. e773-e775
hdl: 1887/3483888
doi: 10.1111/jdv.18291